Literature DB >> 11061948

Essential role for G proteins in prostate cancer cell growth and signaling.

P F Kue1, Y Daaka.   

Abstract

PURPOSE: G proteins are involved in the regulation of multiple cellular functions, including metabolism and proliferation. We studied the role of Gi/o protein subunits in the growth and survival of prostate cancer cells.
MATERIALS AND METHODS: We investigated the effects of pertussis toxin and the G beta gamma sequestrant peptide G protein coupled receptor kinase 2 carboxy terminus on the growth and mitogenic signaling of prostate cells.
RESULTS: Pertussis toxin treatment inhibited the lysophosphatidic acid and serum mediated growth of prostate cancer PC-3 cells by 70% to 80% but showed no effect on insulin-like growth factor 1 (IGF-1) or epidermal growth factor (EGF) mediated growth of these cells. Growth and survival of cells are dependent on activation of intracellular signaling cascades, including those of the mitogen activated protein kinase and Akt pathways. Treatment of the PC-3 cells with lysophosphatidic acid, EGF or serum induced an 8-fold increase in the phosphorylation levels of the mitogen activated protein kinases Erk 1 and 2, and a 3-fold increase in the phosphorylation level of Akt. Erk 1/2 and Akt phosphorylation by lysophosphatidic acid and serum was inhibited by pertussis toxin, suggesting a Gi/o subunit dependent mechanism. EGF and IGF-1 mediated increase in phosphorylation of Erk 1/2 and Akt was independent of pertussis toxin action. Expression of the G beta gamma sequestrant peptide G protein coupled receptor kinase 2 carboxy terminus inhibited the lysophosphatidic acid and serum mediated activation of Erk 1/2 and Akt but showed no effect on the IGF-1 or EGF mediated response. Finally, we showed that activation of the Erk 1/2 pathway in the prostate cancer cells by lysophosphatidic acid and serum is dependent on the EGF receptor and c-Src protein tyrosine kinases. Whereas activation of Akt by these stimuli is not dependent on protein tyrosine kinase activation, it is mediated by PI3K.
CONCLUSIONS: These data indicate that lysophosphatidic acid and serum induce proliferation and mitogenic signaling of prostate cancer cells. Importantly, the serum mediated growth of these cells is dependent on Gi beta gamma subunits, suggesting an important regulatory role for G proteins in the growth of prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11061948

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

2.  CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation.

Authors:  C P El-Haibi; R Singh; P K Sharma; S Singh; J W Lillard
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

3.  The essential role of Giα2 in prostate cancer cell migration.

Authors:  Miao Zhong; Shineka Clarke; BaoHan T Vo; Shafiq A Khan
Journal:  Mol Cancer Res       Date:  2012-08-30       Impact factor: 5.852

4.  Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

Authors:  Kasem Nithipatikom; Marilyn A Isbell; Michael P Endsley; Jeffrey E Woodliff; William B Campbell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-12-15       Impact factor: 3.072

5.  Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.

Authors:  Silvia Caggia; HimaBindu Chunduri; Ana C Millena; Jonathan N Perkins; Smrruthi V Venugopal; BaoHan T Vo; Chunliang Li; Yaping Tu; Shafiq A Khan
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

6.  Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.

Authors:  Liza Barki-Harrington; Angela L Bookout; Gaofeng Wang; Maria E Lamb; L M Fredrik Leeb-Lundberg; Yehia Daaka
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

7.  Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway.

Authors:  Cong Cao; Xuesong Huang; Yuyuan Han; Yinsheng Wan; Lutz Birnbaumer; Geng-Sheng Feng; John Marshall; Meisheng Jiang; Wen-Ming Chu
Journal:  Sci Signal       Date:  2009-04-28       Impact factor: 8.192

8.  Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.

Authors:  Feng Hao; Mingqi Tan; Xuemin Xu; Jiahuai Han; Duane D Miller; Gabor Tigyi; Mei-Zhen Cui
Journal:  Biochim Biophys Acta       Date:  2007-04-24

9.  Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.

Authors:  Yan Lu; Chien-Ming Li; Zhao Wang; Charles R Ross; Jianjun Chen; James T Dalton; Wei Li; Duane D Miller
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

10.  Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.

Authors:  Shinji Sakamoto; Masahiro Yokoyama; Xianghua Zhang; Kulkarni Prakash; Kaori Nagao; Takashi Hatanaka; Robert H Getzenberg; Yoshiyuki Kakehi
Journal:  Endocrinology       Date:  2004-02-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.